- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Rational Use
- All > Medicine Access and Rational Use > Supply Management
(2011; 16 pages)
Derosena, M. 2011. Challenges in Changing Diarrhea Treatment Policy in Senegal. Submitted to the US Agency for International Development by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington, VA: Management Sciences for Health.
The SPS technical assistance and support from other donors, especially UNICEF, were critical to implementing the new diarrhea treatment policy. SPS activities in Senegal will be discontinued at the end of September 2011 and DANSE will need more support to accomplish the process and reinforce IMCI interventions in general. The leadership and governance issues need to be addressed shortly. In the meantime, the ZPC should continue to provide immediate backup to DANSE with support from the Ministry’s second technical advisor in particular who is familiar with the situation. The ZPC could assist DANSE in preparing and updating a plan of action that would include the ZPC’s commitment to follow progress through regularly scheduled meetings, the search for additional financial and human resources, and to prepare a supervision and in-service training plans. In addition, the ZPC and DANSE could work together to identify mechanisms for collecting IMCI drug management data and quantify, prepare, and adjust the procurement and distribution plans according to needs.
Assuming that coordination among donors will be reinforced and maintained however, DANSE will need to put in place appropriate mechanisms to continue IMCI drug management activities. The success of IMCI interventions and implementation of the diarrhea treatment policy in particular depend largely on the existence of operational mechanisms for follow-up and effective coordination of the technical assistance being provided by partners and the commitment of the ZPC.